A detailed history of Hedges Asset Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Hedges Asset Management LLC holds 107,000 shares of VTRS stock, worth $1.34 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
107,000
Previous 102,500 4.39%
Holding current value
$1.34 Million
Previous $1.09 Million 14.05%
% of portfolio
0.86%
Previous 0.82%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.32 - $12.13 $46,440 - $54,585
4,500 Added 4.39%
107,000 $1.24 Million
Q2 2024

Jul 19, 2024

BUY
$10.05 - $12.02 $105,525 - $126,210
10,500 Added 11.41%
102,500 $1.09 Million
Q1 2024

Apr 24, 2024

BUY
$11.27 - $13.53 $90,160 - $108,240
8,000 Added 9.52%
92,000 $1.1 Million
Q4 2023

Jan 10, 2024

BUY
$8.77 - $10.85 $48,235 - $59,675
5,500 Added 7.01%
84,000 $909,000
Q3 2023

Oct 31, 2023

BUY
$9.59 - $11.35 $105,490 - $124,850
11,000 Added 16.3%
78,500 $774,000
Q2 2023

Jul 13, 2023

SELL
$9.02 - $10.29 $5,412 - $6,173
-600 Reduced 0.88%
67,500 $673,000
Q1 2023

Apr 18, 2023

BUY
$9.2 - $12.26 $59,799 - $79,690
6,500 Added 10.55%
68,100 $655,000
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $56,680 - $75,140
-6,500 Reduced 9.54%
61,600 $685,000
Q3 2022

Oct 18, 2022

SELL
$8.48 - $11.13 $4,240 - $5,565
-500 Reduced 0.73%
68,100 $580,000
Q2 2022

Jul 26, 2022

SELL
$9.95 - $12.27 $235,058 - $289,866
-23,624 Reduced 25.62%
68,600 $718,000
Q1 2022

May 10, 2022

BUY
$9.81 - $15.4 $255,060 - $400,400
26,000 Added 39.26%
92,224 $1 Million
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $800,648 - $972,168
66,224 New
66,224 $896,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hedges Asset Management LLC Portfolio

Follow Hedges Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hedges Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hedges Asset Management LLC with notifications on news.